학술논문

Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study
Document Type
Article
Source
The Lancet Child & Adolescent Health; November 2022, Vol. 6 Issue: 11 p788-798, 11p
Subject
Language
ISSN
23524642; 23524650
Abstract
Data on medium-term outcomes in indivduals with myocarditis after mRNA COVID-19 vaccination are scarce. We aimed to assess clinical outcomes and quality of life at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults.